Fundraising FoxDiamond Edge Ventures
Corporate VCSan Francisco · Seed–Series A · 10 people tracked
Find your way into Diamond Edge Ventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask Masatoshi Chiba to introduce you to Takashi
You →Masatoshi · together at Mitsubishi Chemical Corporation →Takashi
Ask Jamie Chen to introduce you to Curtis Schickner
You →Jamie · together at Diamond Edge Ventures, Mitsubishi Chemical Group →Curtis
Ask Sam Okafor to introduce you to Stefan Schnippering
You →Sam · together at Mitsubishi Chemical Europe →Stefan
- Naoko Miyashita101 people can intro you
- Kyalo Stephen Kanyiva82 people can intro you
- Naveed Ahmed24 people can intro you
Sign up to find every way you can get introduced to Diamond Edge Ventures
- Your email: who you already know at Diamond Edge Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Diamond Edge Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Diamond Edge Ventures (DEV) is the venture capital entity of Mitsubishi Chemical Group, backing technology startups with the potential to transform MCG's core markets and future businesses. It offers portfolio companies pathways to co-development and commercialization with Mitsubishi Chemical Group business units, supported by a dedicated commercialization team. Focus areas span electric vehicles and mobility, advanced and lightweight materials, polymers/films/coatings, electronics/sensors/display/semiconductors, health and medical devices, food ingredients and packaging, green materials/recycling/renewable energy, and advanced manufacturing. The firm plans to deploy $200M through 2030 and operates globally with team members across the US, Japan, and Europe.
Source: firm website, verified Sep 20, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 17 of 18 portfolio companiesBiotech ×7Deep Tech ×7New Materials ×7Cleantech ×6AI & Machine Learning ×4Advanced Manufacturing ×3Circular Economy ×3Hardware ×3
HQs:United States×7United Kingdom×3Australia×1Canada×1France×1Japan×1
Investments · 18 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 22023 · 22022 · 22018 · 210 dated
Licella is a developer of hydrothermal liquefaction technology that converts low-cost waste biomass into advanced biofuels, including sustainable aviation fuel (SAF), renewable diesel, and biomaterials.
BiotechCircular EconomyCleantechEnergyNorth Sydney, AU
Dr Len Humphreys(Executive Chairman)Professor Thomas Maschmeyer AO
iAM Marketplace is an online marketplace for additive manufacturing, offering materials such as filaments, photopolymers, and powders alongside hardware, accessories, certified pre-owned equipment, and related services and solutions.
Advanced ManufacturingB2B MarketplacesNew Materials
Co-investorsWest Hill Capital
BO Materials develops novel materials for industrial applications across trillion-dollar industries.
AI & Machine LearningDeep TechNew MaterialsSemiconductorsMassachusetts, US
Michael Segal(Executive Officer, Director)inAnvesh Gurijala(Founder)
BoardDavid Miller(Director)inDwight Poler(Director)Andrew Goldman(Director)
Co-investorsAccelr8ACVC PartnersClean Energy VentureClean Energy VenturesCollaborative FundGC Ventures+5 more
Plant-based meat 'Miracle Meat' from germinated soybeans
Co-investorsGlobal BrainKDDI Open Innovation Fund
DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process.
Deep TechHardwareNew MaterialsSunnyvale, US
Jonathan Waldern(Director)inChristopher Pickett(Executive Officer, Director)Patrick Suel(Director)Robert Young(Director)Thorsten Alexander Kern(Director)
BoardJim Whims(Director)
Co-investorsAlsop Louie PartnersBold Capital PartnersDolby Family VenturesNautilus Ventures Management Company (Us), LlcSony Ventures CorporationMITSUBISHI CHEMICAL+1 more
Lingrove designs and manufactures Ekoa, a bio-based composite made from renewable flax and plant resins used as impact-resistant wall protection, wall coverings, ceilings, and millwork for hospitality, healthcare, senior living, and workplace interiors.
CleantechConstruction TechNew Materials
Joe Luttwak(Founder)
Co-investorsSnatched VenturesSoundboard Venture FundIndieBioSOSV
Eridan builds Software Defined Radios for Private 5G networks, using a proprietary Switch-Mode Direct Polar transmitter with Gallium Nitride power stages to deliver higher signal fidelity and lower power consumption than conventional radios.
AI & Machine LearningDeep TechHardwareIoTRoboticsSemiconductorsSunnyvale, US
Vivek Pathak(Executive Officer)inDouglas A Kirkpatrick(Executive Officer, Director)Amy Lamboley(Executive Officer)inSusan Kamin(Executive Officer)Paul Draxler(Executive Officer)inDoug Kirkpatrick(Founder)
Co-investorsEvolution VC PartnersMonta Vista CapitalPage One VenturesRising TideSand Hill AngelsSilicon Catalyst+3 more
Yokogawa Fluence Analytics develops patented process analytics and control technologies, including its ACOMP system for real-time polymer reaction monitoring and its ARGEN static light scattering instrument for biopolymer stability testing.
Advanced ManufacturingAI & Machine LearningBiotechHardwareIoT
Co-investorsEnergy Innovation CapitalMITSUBISHI CHEMICAL
Freshr Technologies develops active packaging technology designed to extend the shelf life of fresh food and reduce waste.
Circular EconomyCleantechFoodTechNew Materials
Dr. Mina Mekhail(Founder and CEO)
Co-investorsNàdarra Ventures
Lactips produces natural, biobased polymers derived from protein that are biodegradable and water-soluble, addressing microplastic pollution across industrial applications.
Circular EconomyCleantechNew MaterialsSaint-Paul-en-Jarez, FR
Co-investorsBlue Ocean Capital GroupBNP Paribas DéveloppementBpifranceDemeterGO CapitalSWEN Capital Partners
Lingrove designs and manufactures Ekoa, a bio-based composite material made from flax and plant resins used as wall protection, wall coverings, ceilings, and millwork for hospitality, healthcare, and workplace interiors, as well as automotive interior applications.
CleantechConstruction TechNew MaterialsSan Rafael, US
Joseph Luttwak(Executive Officer, Director)in
BoardTalley Goodson(Director)Thomas Crow(Director)Stephen P. Welker(Director)
Co-investorsBoro CapitalCool Climate CollectiveSeaX VenturesSoundboard Venture FundHelium-3 VenturesIndieBio+2 more
Myoridge develops serum-free cell culture media and optimization services for cell cultivation and regenerative medicine applications.
BiotechHealthtechMedical DevicesJapan, JP
Co-investorsBeyond Next VenturesKyoto University Innovation Capital
Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases.
BiotechDeep TechDundee, GB
Satpal Virdee(Founder)
Co-investorsM VenturesMC Healthcare Ventures
PharmEnable applies AI to small molecule drug discovery, focusing on challenging and data-sparse biological targets that traditional methods struggle to address.
AI & Machine LearningBiotechDeep Tech
Hannah Sore(Founder)in
Co-investorsCambridge Angels groupMartlet CapitalMC Healthcare VenturesO2h VenturesParkwalk AdvisorsWren Capital
Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.
ConsumerFoodTech
Kimberlie Le(Founder)inJoshua Nixon(Founder)
Co-investorsAlumni VenturesCollaborative FundDnx VenturesPangaea Ventures Us Inc.PortfoliaSpiral Sun Ventures+8 more
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsALS Investment FundDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission Biocapital+8 more
TRIMTech Therapeutics is a biotechnology company focused on drug discovery and development, backed by investors including Cambridge Innovation Capital and BGF.
BiotechDeep TechLongevityMedical DevicesCambridge, GB
Damian Crowther, PhD FRCP(Co-founder, Head of Research)Dr. Leo James(Co-founder, Group Leader at MRC Laboratory of Molecular Biology)Dr. William McEwan(Co-founder, Group Leader at UK Dementia Research Institute, University of Cambridge)Nicki Thompson, PhD(CEO)Nicki Thompson(CEO)
Co-investorsCambridge Innovation CapitalPfizer VenturesSV Health InvestorsM VenturesPfizer Venture InvestmentsStart Codon
Advanced ManufacturingCleantechGolden, US
Andrew Maxey(Executive Officer, Director)inAaron Parker(Executive Officer)inDaniel Flagg(Executive Officer)inSean Kline(Executive Officer)inShari Kennett(Director)J. Scott Pusey(Executive Officer)
Co-investorsAutodesk FoundationBelle Impact FundBeyond CapitalCircular Innovation FundE8 AngelsHG Ventures+8 more
Portfolio news
latest coverage across their companiesFreshr · finsmes.com · May 13, 2025
Frequently asked questions
- How many investments has Diamond Edge Ventures made?
- Diamond Edge Ventures has 18 tracked investments, including 3 dated in the last 24 months.
- What stage does Diamond Edge Ventures invest at?
- Diamond Edge Ventures invests at the Seed, Series A stages.
- What sectors does Diamond Edge Ventures focus on?
- Diamond Edge Ventures focuses on Advanced Manufacturing, Biotech, Circular Economy, Cleantech, Deep Tech, Energy, FoodTech, Hardware, Medical Devices, Mobility & Transportation, New Materials, Semiconductors.
- Where is Diamond Edge Ventures located?
- Diamond Edge Ventures is headquartered in San Francisco, US.
- Does Diamond Edge Ventures lead rounds?
- Diamond Edge Ventures has led 3 of the 7 rounds where its role is on record.
- Who does Diamond Edge Ventures co-invest with?
- Diamond Edge Ventures most often shares deals with Collaborative Fund, Global Brain, Monta Vista Capital, among 50 tracked co-investors.
Images
Similar investors
Oost NL is a regional development agency that supports and connects innovative entrepreneurs in the Dutch provinces of Gelderland and Overijssel, helping accelerate technological innovation through capital, network, and knowledge.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
Qbic is an inter-university venture capital fund that backs the transformation of technological breakthroughs from its academic and research partners into sustainable businesses.
Range is a venture capital firm that invests in founders building novel solutions in overlooked or challenging categories. The firm focuses on consensus founders with unique insights, backing companies at various stages across diverse sectors.